Table 2.
Model effects | df | PL1 | PL2 | PL3 | NEV1 | NEV2 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
χ2 | p | χ2 | p | χ2 | p | χ2 | p | χ2 | p | ||
| |||||||||||
Time | 3 | 6.86 | 0.08 | 1.35 | 0.72 | 39.77 | <0.01 | 16.85 | <0.01 | 3.80 | 0.28 |
Treatment | 1 | 0.03 | 0.86 | 0.56 | 0.45 | 24.32 | <0.01 | 1.36 | 0.24 | 0.02 | 0.88 |
Biotype | 2 | 437.12 | <0.01 | 48.88 | <0.01 | 0.44 | 0.80 | 9.62 | <0.01 | 3.50 | 0.17 |
Time × Treatment | 3 | 4.88 | 0.18 | 1.20 | 0.75 | 14.81 | <0.01 | 0.85 | 0.84 | 4.26 | 0.24 |
Time × Biotype | 6 | 22.33 | <0.01 | 12.22 | 0.06 | 13.79 | 0.03 | 13.48 | 0.04 | 5.68 | 0.46 |
Treatment × Biotype | 2 | 3.02 | 0.22 | 2.23 | 0.33 | 0.40 | 0.82 | 1.32 | 0.52 | 0.16 | 0.92 |
Time × Treatment × Biotype | 6 | 17.02 | <0.01 | 3.73 | 0.71 | 10.74 | 0.10 | 18.21 | <0.01 | 6.57 | 0.36 |
Abbreviations: df: degree of freedom; NEV: neuronal origin-enriched extracellular vesicle factor; SHAPS: Snaith-Hamilton Pleasure Scale; PL: plasma cytokine factor; ΔSHAPS: (SHAPSWeek 6 or 12 − SHAPSWeek 0)/SHAPSWeek 0